Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Physical and Work Variables in Professional Musicians (SActMWQoLMU)

14. August 2022 aktualisiert von: GEMMA V ESPÍ LÓPEZ, PhD, University of Valencia

Physical Activity, Musculoskeletal Disorders, Perception of Emotional Work Well-being and Quality of Life in Professional Musicians

In professional musicians there are characteristic diseases. In this area there is no preventive culture and many musicians end their professional careers due to ailments and pathologies that cause the abandonment of the profession or they learn to live and play with pain. It is a very demanding profession that requires many hours of training without respecting the necessary rest, which undoubtedly produces fatigue and muscle overload, neurological disorders, etc. Also, the demands to achieve perfection lead to serious work problems.

Given that it is a profession that suffers from pain and psychosomatic alterations and that is often accompanied by emotional alterations due to work demands, it is necessary to know this problem and to what extent it affects the musician to be able to act from different areas and improve his well-being.

The objective is to know specifically the characteristics of professional musicians, their impact variables, both musculoskeletal and emotional, variables related to the workplace and to evaluate their quality of life.

Studienübersicht

Status

Abgeschlossen

Intervention / Behandlung

Detaillierte Beschreibung

MATERIAL AND METHODS Subjects. Professional orchestral and band musicians between the ages of 18 and 65.

Study design. Descriptive study to be carried out at the University of Valencia. To do this, a survey will be carried out through an online platform. All participants will sign the informed consent and the study will be carried out in compliance with the data confidentiality guidelines. To start the study, the approval of the Ethics Committee of the University of Valencia will be necessary and it will be included in an international registry.

Evaluation. In the first place, the anthropometric data (age, sex, weight, height) and the characteristics of the sample will be taken through an interview designed for this study that will contain questions about the job and instruments they practice. Subsequently, the subjects will fill in the assessment instruments that include the physical activity they perform, the musculoskeletal alterations, workplace harassment, professional burnout, quality of life and anxiety and depression.

Statistic analysis. The variables will be coded and analyzed using the SPSS v.26 program.

Studientyp

Beobachtungs

Einschreibung (Tatsächlich)

156

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

      • Valencia, Spanien, 46010
        • Gemma Victoria Espí-López
      • Valencia, Spanien, 46010
        • Gemma Espí López

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 65 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Wahrscheinlichkeitsstichprobe

Studienpopulation

Professional musicians of orchestras and bands

Beschreibung

Inclusion Criteria:

  • active professional musicians

Exclusion Criteria:

  • non-active or non-practicing professional musicians

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Physical activity
Zeitfenster: 1 day
By Ipaq Short Form. The short form records activity at four levels of intensity: 1) vigorous intensity activity such as aerobics, 2) moderate intensity activity such as leisure riding a bike, 3) walking and 4) sitting.
1 day
Musculoskeletal disorders
Zeitfenster: 1 day
Will be evaluated by the Nordic questionnaire, this tool is used to detect symptoms musculoskeletal such as pain, discomfort, numbness or tingling. It includes two important sections: The first is choice questions mandatory in which the subject marks the areas of the body where pain occurs; The second section contains related questions on the functional impact of pain symptoms. Also the duration of problem, if it has been evaluated by a health professional and the evolution of pain. This questionnaire does not have a score as such, it does not have a scale to assess it, but rather what, based on the data, the analysis is extracted for each question.
1 day

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Workplace Harassment
Zeitfenster: 1 day
To assess mobbing at work we used the Short-Negative Acts Questionnaire (NAQ). It consists of 9 items of the NAQ. This is a questionnaire that collects typical harassment behaviors, with respect to which the subject must indicate the degree to which they have suffered such behaviors during the last six months. The response scale consists of five alternatives from 1 ("never") to 5 ("daily"). Some examples of the items included are: "Gossip and rumors have spread about me", "I have been the object of offenses about my person or my private life".
1 day
Health
Zeitfenster: 1 day

The SF-8 questionnaire is structured with eight articles. It is divided into eight subscales (physical functioning, physical role, body pain, general health, vitality, social functioning, emotional role mental and mental health) and two summary components (physical and mental) through which the the results are expressed.

Scores on the subscales and summary. The components are presented as a mean score of 50. Therefore, scores below 50 points correspond to deviations from normality and indicate a poorer quality of life, while scores above 50 the points represent a better quality of life.

1 day
Anxiety and depression
Zeitfenster: 1 day

The Golberg scale will be used, a test that orients the diagnosis towards anxiety or depression or both, and discriminates between them and measures their respective intensities. This scale contains 2 subscales with 9 questions each:

  • Anxiety subscale (questions 1-9). If from questions 1-4, a minimum of 2 questions are not answered in the affirmative, the test is not carried out.
  • Depression subscale (questions 10-18). If from questions 10-13, a minimum of 1 questions are not answered in the affirmative, the test is not carried out.

For its interpretation, the affirmative responses of the Anxiety scale and those of the Depression scale are counted. The cut-off points are 4 or more for the Anxiety subscale and 2 or more for Depression, with scores that are higher the more severe the problem (the maximum possible being 9 in each of the subscales). .

1 day
Professional burnout
Zeitfenster: 1 day
The Brief Burnout Questionnaire (CBB) will be used. This questionnaire aims to define the Burnout Syndrome or professional burnout syndrome and understand its dimensions. Burnout Syndrome can be defined as the symptoms of exhaustion and emotional exhaustion, the presence of depersonalization and the lack of personal fulfillment that is generated through a process of work stress maintained over time. Three dimensions are contemplated that include the previous factors of Burnout, the development of Burnout Syndrome and the consequences of this Syndrome. The antecedent factors of Burnout include items related to dissatisfaction with the task performed and with the organization in the workplace. The CBB questionnaire consists of 21 items that are evaluated by quantifying the global affectation of the subject by Burnout Syndrome in low, medium or high affectation in each of the three categories mentioned above.
1 day

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Gemma V E Espí-López, Dr, University of Valencia

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

10. Oktober 2021

Primärer Abschluss (Tatsächlich)

7. Januar 2022

Studienabschluss (Tatsächlich)

18. Januar 2022

Studienanmeldedaten

Zuerst eingereicht

8. September 2021

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

8. September 2021

Zuerst gepostet (Tatsächlich)

17. September 2021

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

16. August 2022

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

14. August 2022

Zuletzt verifiziert

1. August 2022

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • ID0035

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Muskel-Skelett-Schmerzen

3
Abonnieren